Cargando…
MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma
BACKGROUND: Glioma is the most prevalent malignant tumor in human central nervous systems. Recently, the development of resistance to radiotherapy in glioma patients markedly vitiates the therapy outcome. MiR-153-3p has been reported to be closely correlated with tumor progression, but its effect an...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288870/ https://www.ncbi.nlm.nih.gov/pubmed/30537994 http://dx.doi.org/10.1186/s40659-018-0203-6 |